Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-Wall St gains on earnings; S&P up for 6th straight day

Tue, 22nd Apr 2014 15:59

* S&P 500, Nasdaq on track for six-day advance

* Netflix up after results, Facebook gains on update

* Allergan soars as Ackman and Valeant bid for company

* Indexes up: Dow 0.6 pct, S&P 0.5 pct, Nasdaq 0.9 pct (Updates to midday trading)

By Ryan Vlastelica

NEW YORK, April 22 (Reuters) - U.S. stocks rose on Tuesday,with both the S&P 500 and Nasdaq on track for a sixth straightday of gains as a number of bellwether companies reported strongresults.

Netflix Inc surged 6 percent to $369.33 a day afterresults showed strong subscriber growth, a sign the tradingfavorite still had room to grow despite recent concerns over itsvaluation. With the day's gain, the stock returned to slightlypositive territory for the year after a 21-percent decline inMarch.

Also helping lift the Internet space was Facebook Inc, which rose 2.5 percent to $62.80 after Credit Suisseupgraded the social networking company to "outperform" on higherexpectations for the company's long-term average revenue peruser.

Dow components Travelers Cos Inc and UnitedTechnologies Corp both reported first-quarter earningsthat beat expectations, and United Tech raised the low end ofits full-year profit outlook. Shares of Travelers rose 0.2percent to $86.58 while United Tech was up 1.2 percent at$119.69.

McDonald's Corp reported earnings that fellalongside a drop in U.S. same-store sales, but shares of the Dowcomponent rose 0.2 percent to $99.88.

Better-than-expected earnings have lifted equities recently,though companies have largely been exceeding reduced forecasts.Profits are seen rising 1.1 percent this quarter, down from the6.5 percent growth rate estimated at the start of the year.

"The season has been better than many have feared, which ishelping investors feel comfortable with the pace of economicgrowth, not just in the first quarter but going forward," saidJoseph Tanious, global market strategist at J.P. Morgan AssetManagement in New York.

With 20 percent of the S&P having reported, 63 percent havetopped earnings expectations, according to Thomson Reuters data,even with the long-term average. On revenue, 51 percent haveexceeded forecasts, below the 61 percent long-term average.

The Dow Jones industrial average was up 92.93 points,or 0.56 percent, at 16,542.18. The Standard & Poor's 500 Index was up 9.50 points, or 0.51 percent, at 1,881.39. TheNasdaq Composite Index was up 38.44 points, or 0.93percent, at 4,159.99.

Both the S&P and Nasdaq are on track for a sixth straightday of gains. The S&P has gained 3.6 percent over that periodwhile the Nasdaq is up 4 percent.

In company news, Allergan Inc jumped 15 percent to$163.58 a day after activist investor William Ackman teamed upwith Canadian drugmaker Valeant Pharmaceuticals InternationalInc to bid for the company.

In the latest economic data, existing home sales fell totheir lowest level in more than 1-1/2 years in March, though thedecline was narrower than expected. (Editing by Nick Zieminski)

More News
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.